Action 719 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shandong Xinhua Pharmaceutical Company Limited

Actions

719

CNE100000411

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:08:09 16/07/2024 		Varia. 5j. Varia. 1 janv.
5,28 HKD -0,38 % Graphique intraday de Shandong Xinhua Pharmaceutical Company Limited -2,22 % -8,65 %
26/06 Shandong Xinhua Pharmaceutical Company Limited approuve le dividende final en espèces pour l'exercice clos le 31 décembre 2023, payable le 30 juillet 2024 CI
20/06 Xinhua Pharmaceutical obtient le feu vert pour enregistrer ses gélules de prégabaline MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shandong Xinhua Pharmaceutical Company Limited Approves Final Cash Dividend for the Year Ended 31 December 2023, Payable on 30 July 2024
Xinhua Pharmaceutical Gets Nod to Register Pregabalin Capsules
Shandong Xinhua Pharmaceutical Company Limited Obtains Drug Registration Certificate on Pregabalin Capsules
Shandong Xinhua Pharmaceutical's Two Drugs Pass Chinese Drug Regulator's Consistency Evaluation
Shandong Xinhua Pharmaceutical Company Limited Receives the Notice of Approval of Supplementary Drug Application from the National Medical Products Administration
Shandong Xinhua Pharmaceutical Company Limited Receives the Notice of Approval of Supplementary Drug Application from the National Medical Products Administration
Xinhua Pharmaceutical’s Sodium Bicarbonate Injection Passes Generic Drug Evaluation in China
Shandong Xinhua Pharmaceutical Company Limited Receives Notice of Approval of Supplementary Drug Application from the National Medical Products Administration
Xinhua Pharmaceutical's Depression Drug Gets Registration Approval in China
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of Escitalopram Oxalate Tablets
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit
Shandong Xinhua Pharmaceutical Proposes New Auditor
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Xinhua Pharma's Ibuprofen Gets Registration Approval in China
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 719
  4. Actualités Shandong Xinhua Pharmaceutical Company Limited
  5. Autres langues